Atorvastatin and almonertinib-induced myopathy in a polypharmacy context: a case report
-
By
-
Jifang Zhou
-
Lixia Yu
-
Huimin Xu
-
May 14, 2026
-
Clinical Scorecard: Myopathy Associated with Atorvastatin and Almonertinib in a Patient on Multiple Medications: A Case Study
At a Glance
| Category | Detail |
|---|
| Condition | |
| Key Mechanisms | |
| Target Population | Elderly patients (89 years old) with coronary heart disease and lung cancer. |
| Care Setting | |
Key Highlights
- Patient was on multiple medications including olanzapine and zopiclone.
Guideline-Based Recommendations
Diagnosis
Management
- Consider alternative cholesterol-lowering agents such as ezetimibe in patients requiring both statins and EGFR-TKIs.
Monitoring & Follow-up
Risks
Patient & Prescribing Data
Consider the impact of multiple comorbidities on the choice of cholesterol-lowering agents.
Clinical Best Practices
- Educate patients about potential drug interactions and the importance of reporting symptoms.
Related Resources & Content
